0001493152-24-011836.txt : 20240328
0001493152-24-011836.hdr.sgml : 20240328
20240328210008
ACCESSION NUMBER: 0001493152-24-011836
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240326
FILED AS OF DATE: 20240328
DATE AS OF CHANGE: 20240328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alder Matthias
CENTRAL INDEX KEY: 0001370820
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40237
FILM NUMBER: 24801697
MAIL ADDRESS:
STREET 1: C/O MICROMET, INC.
STREET 2: 6707 DEMOCRACY BLVD., STE. 505
CITY: BETHESDA
STATE: MD
ZIP: 28017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gain Therapeutics, Inc.
CENTRAL INDEX KEY: 0001819411
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851726310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: (301) 500-1556
MAIL ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
ownership.xml
X0508
4
2024-03-26
0
0001819411
Gain Therapeutics, Inc.
GANX
0001370820
Alder Matthias
C/O GAIN THERAPEUTICS, INC.
4800 MONTGOMERY LANE, SUITE 220
BETHESDA
MD
20814
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-03-26
4
M
0
18750
A
25763
D
Common Stock
2024-03-26
4
M
0
825
A
26588
D
Common Stock
2024-03-26
4
M
0
637
A
27225
D
Common Stock
2024-03-26
4
F
0
6085
4.06
D
21140
D
Restricted Stock Units
2024-03-26
4
M
0
18750
0.00
D
Common Stock
18750
56250
D
Restricted Stock Units
2024-03-26
4
M
0
825
0.00
D
Common Stock
249
8250
D
Restricted Stock Units
2024-03-26
4
M
0
637
0.00
D
Common Stock
192
6376
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
/s/ Matthias Alder
2024-03-28